Mylan bags license to commercialize Fujifilm’s Humira biosimilar in Europe
Through the partnership agreement, Mylan will leverage its regulatory platform to seek approval and commercialize the product in Europe. Humira is a TNF-inhibitor aimed at treating multiple chronic inflammatory